Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ioannis Grigoropoulos"'
Autor:
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Orr Green, Vasiliki Rapti, Maria Tsakona, Thomas Konstantinos, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Konstantinos Syrigos, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Garyfalia Poulakou, Mina Gaga, Ronan MacLoughlin, Justin Stebbing, Nadir Arber, Anastasia Antoniadou, Sotirios Tsiodras
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Introduction EXO-CD24 are exosomes genetically manipulated to over-express Cluster of Differentiation (CD) 24. It consists of two breakthrough technologies: CD24, the drug, as a novel immunomodulator that is smarter than steroids without any
Externí odkaz:
https://doaj.org/article/24f5adc7c431420c90c68b1ab0f43b4a
Autor:
Georgios Tsioulos, Ioannis Grigoropoulos, Charalampos D. Moschopoulos, Shiran Shapira, Garyfallia Poulakou, Anastasia Antoniadou, Dimitrios Boumpas, Nadir Arber, Sotirios Tsiodras
Publikováno v:
Life, Vol 12, Iss 10, p 1472 (2022)
Cluster of differentiation (CD) 24, a long-known protein with multifaceted functions, has gained attention as a possible treatment for Coronavirus Disease 19 (COVID-19) due to its known anti-inflammatory action. Extracellular vesicles (EVs), such as
Externí odkaz:
https://doaj.org/article/47155fe8369b4be4aae3279173ff7222
Autor:
Fotinie Ntziora, Evangelia Georgia Kostaki, Ioannis Grigoropoulos, Amalia Karapanou, Ismini Kliani, Maria Mylona, Alexa Thomollari, Sotirios Tsiodras, Theoklis Zaoutis, Dimitrios Paraskevis, Nikolaos V. Sipsas, Anastasia Antoniadou, Petros P. Sfikakis
Publikováno v:
Viruses, Vol 14, Iss 1, p 26 (2021)
Health-Care-Workers (HCWs) are considered at high risk for SARS-CoV-2 infection. We sought to compare rates and severity of Coronavirus disease 2019 (COVID-19) among vaccinated and unvaccinated HCWs conducting a retrospective cohort study in two tert
Externí odkaz:
https://doaj.org/article/cd765cb1ed064753a5136167cab5ccd5
Autor:
Konstantinos Thomas, Ioannis Grigoropoulos, Panagiota Alexopoulou, Emmanouil Karofylakis, Eirini Galani, Kyriaki Korina Papadopoulou, Anastasia Tsiavou, Aliki Ntourou, Eleftheria Mavrou, Irina Qevani, Pelagia Katsimbri, Christos Koutsianas, Evgenia Mavrea, Dimitrios Vassilopoulos, Spyros Pournaras, Sotirios Tsiodras, Dimitrios Boumpas, Anastasia Antoniadou
Publikováno v:
Rheumatology.
Objectives B cell depleting monoclonal antibodies are associated with increased COVID-19 severity and impaired immune response to vaccination. We aimed to assess the humoral and cell mediated (CMI) immune response after SARS-CoV-2 vaccination in ritu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e1246509d33b27a8786bbc11e2fbce3
https://doi.org/10.1093/rheumatology/kead236
https://doi.org/10.1093/rheumatology/kead236
Autor:
Fotinie Ntziora, Evangelia Georgia Kostaki, Ioannis Grigoropoulos, Amalia Karapanou, Ismini Kliani, Maria Mylona, Alexa Thomollari, Sotirios Tsiodras, Theoklis Zaoutis, Dimitrios Paraskevis, Nikolaos V. Sipsas, Anastasia Antoniadou, Petros P. Sfikakis
Publikováno v:
Viruses, Vol 14, Iss 26, p 26 (2022)
Viruses; Volume 14; Issue 1; Pages: 26
Viruses
Viruses; Volume 14; Issue 1; Pages: 26
Viruses
Health-Care-Workers (HCWs) are considered at high risk for SARS-CoV-2 infection. We sought to compare rates and severity of Coronavirus disease 2019 (COVID-19) among vaccinated and unvaccinated HCWs conducting a retrospective cohort study in two tert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa89dde2a8609793ceb1a7e9ff6429b
https://www.mdpi.com/1999-4915/14/1/26
https://www.mdpi.com/1999-4915/14/1/26
Autor:
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Nadir Arber, Garyfallia Poulakou, Konstantinos Syrigos, Vasiliki Rapti, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Mina Gaga, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Maria Tsakona, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Anastasia Antoniadou, Sotirios Tsiodras
Publikováno v:
Open Forum Infectious Diseases. 9
Background EXO-CD24 is a novel inhaled drug of exosomes displaying CD24, a protein with anti-inflammatory properties. We evaluated the safety and potential efficacy of EXO-CD24, in a phase II, randomized, single-blinded clinical trial of EXO-CD24 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18d967e4befa8a8f9d4cf7b1907fa704
https://doi.org/10.1093/ofid/ofac492.991
https://doi.org/10.1093/ofid/ofac492.991
Autor:
Petros P. Sfikakis, Maria G Tektonidou, Stylianos Panopoulos, Vassiliki-Kalliopi Bournia, Aikaterini Arida, Dimitrios Vassilopoulos, Kalliopi Fragiadaki, George E Fragoulis, Konstantinos Thomas, Anastasios Karamanakos, Ioannis Grigoropoulos, Evgenia Mavrea, Dimitrios Paraskevis, Evrydiki Kravvariti, Gerasimos Evangelatos, Maria Pappa
Publikováno v:
Rheumatology International
To assess non-compliance and potential changes in seasonal flu vaccination coverage before and during the Covid-19 pandemic in patients with autoimmune rheumatic diseases (ARDs). Consecutive patients with ARDs followed-up in 2 tertiary hospitals were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9f6c2bf373ae0a139e6752af98ac2c
https://doi.org/10.1007/s00296-021-04817-3
https://doi.org/10.1007/s00296-021-04817-3
Autor:
Nikolaos Tziolos, Emmanouil Karofylakis, Ioannis Grigoropoulos, Pinelopi Kazakou, Emmanouil Koullias, Athina Savva, Hariklia Kranidioti, Aimilia Pelekanou, Anna Boulouta, Maria Pirounaki, Sotirios Tsiodras, Georgios Georgiopoulos, Dimitrios T Boumpas, Dimitra Kavatha, Konstantinos Thomas, Dimitrios Vassilopoulos, Anastasia Antoniadou
Publikováno v:
Open Forum Infectious Diseases
Background Therapeutic options for hospitalized patients with severe coronavirus disease 2019 (sCOVID-19) are limited. Preliminary data have shown promising results with baricitinib, but real-life experience is lacking. We assessed the safety and eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc14eada8050abc72899e954646108f
https://pubmed.ncbi.nlm.nih.gov/34988257
https://pubmed.ncbi.nlm.nih.gov/34988257
